Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...
Patients with multidrug resistant HIV infection who switch to a single tablet of bictegravir/emtricitabine/tenofovir ...
Africanews on MSN
South Africa gives twice-yearly HIV prevention jab the green light
It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback